FAIR VALUE MEASUREMENTS
12 Months Ended
Dec. 31, 2015
Fair Value Disclosures [Abstract]  
FAIR VALUE MEASUREMENTS
NOTE 3:- FAIR VALUE MEASUREMENTS

 

In accordance with ASC No. 820 and ASC No. 825, the Company measures its investment, (see also Note 4) at fair value.

 

The Company's financial assets measured at fair value on a recurring basis consisted of the following types of instruments:

 

    As of December 31, 2015  
    Fair value measurements using input type  
    Level 1     Level 2     Level 3     Total  
                         
                         
Investment in BioCancell   $ 50     $ -     $ -     $ 50  

 

    As of December 31, 2015  
    Fair value measurements using input type  
    Level 1     Level 2     Level 3     Total  
                         
                         
Investment in BioCancell   $ 85     $ -     $ -     $ 85